State Stem Cell Agency ICOC Governance Subcommittee Agenda 8/31/05

Return to CIRM Meetings and Events

California State Stem Cell Agency

Regular Meeting 02-28-05 pres

Presidential Search Sub-Committee
of the Independent Citizens’ Oversight Committee
TO THE CALIFORNIA INSTITUTE FOR REGENERATIVE MEDICINE (CIRM)

Organized Pursuant To The
CALIFORNIA STEM CELL RESEARCH AND CURES ACT

 
 

OPEN SESSION

  1. Call to Order.
  2. Roll Call.

    [Members of the Public will be invited to provide testimony before or during consideration of each agenda item. Speakers are asked to limit their testimony to three (3) minutes.]

  3. Consideration of CIRM President Job summary and criteria and executive search process timeline by SpencerStuart.
 

CLOSED SESSION

  1. Personnel: (Government Code section 11126, subdivision (a); Health & Safety Code section 125290.30(d)(3)(D).)(Search for Acting President of the California Institute of Regenerative Medicine)
 

OPEN SESSION

  1. Public report of any action taken, if necessary, during closed session.
  2. Adjournment

 

THE ORDER OF BUSINESS MAY BE CHANGED WITHOUT NOTICE.
Notice is hereby given that the order of consideration of matters on this agenda may be changed without prior notice.

 


 

**NOTICE**

 

The California Institute for Regenerative Medicine and its Independent Citizens Oversight Committee, and any subcommittees thereof, comply with the Americans with Disabilities Act (ADA) by ensuring that the meeting facilities are accessible to persons with disabilities, and providing that this notice and information given to the Members of the Committee is available to the public in appropriate alternative formats when requested. If you need further assistance, including disability-related modifications or accommodations, you may contact Melissa King at the California Institute for Regenerative Medicine at 415-396-9100 no later than the day prior to the meeting.

Questions or requests for additional information prior to the Independent Citizens Oversight Committee meeting may be referred to Melissa King at the California Institute for Regenerative Medicine at mking@cirm.ca.gov or 415-396-9100.

This meeting agenda is also available on the website for the California Institute for Regenerative Medicine at https://www.cirm.ca.gov.

 


Date Published: April 6, 2009
Last Modified: April 5, 2017